Filing Flows › Celestica (CLS) › Q3 2026 › vs Q2 2026
Celestica (CLS) Q3 2026 vs Q2 2026 (quarter over quarter)
Celestica's revenue rose $1.1B (+24%) from $4.7B in Q2 2026 to $5.8B in Q3 2026. The biggest changes: CCS +$1.1B (+28%); ATS +$69.1M (+8%). Gross margin 11.0% against 12.3% (-1.3 pts).
Celestica, Q3 2026: revenue $5.8B (+82% year over year), operating margin 7.9%, net earnings $397M, operating cash flow $390M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 11.0% | 12.3% | -1.3 pts |
| Operating margin | 7.9% | 9.8% | -1.9 pts |
| Net margin | 6.8% | 7.8% | -1.0 pts |
| Free cash flow margin | 2.0% | 3.1% | -1.1 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| CCS | $4.9B | $3.8B | $1.1B | +28% |
| ATS | $957M | $888M | $69.1M | +8% |
| Revenue | $5.8B | $4.7B | $1.1B | +24% |
| Gross profit | $641M | $578M | $63.3M | +11% |
| Cost of revenue | $5.2B | $4.1B | $1.1B | +26% |
| Operating profit | $460M | $458M | $1.7M | +0.4% |
| Operating expenses | $181M | $119M | $61.6M | +52% |
| Pre-tax earnings | $456M | $442M | $14.2M | +3% |
| Research & development | $51.2M | $46.3M | $4.9M | +11% |
| SG&A | $118M | $58.1M | $60.1M | +103% |
| Other operating costs | $11.4M | $14.8M | −$3.4M | -23% |
| Net earnings | $397M | $369M | $28.4M | +8% |
| Income tax | $58.6M | $72.8M | −$14.2M | -20% |
| Depreciation & amortization | $48.5M | $44.0M | $4.5M | +10% |
| Share-based compensation | $21.3M | $19.3M | $2.0M | +10% |
| Working capital & other | $77.3M | $21.2M | $56.1M | +265% |
| Operating cash flow | $390M | $411M | −$21.2M | -5% |
| Free cash flow (OCF − capex) | $116M | $147M | −$31.5M | -21% |
| Capital expenditures | $274M | $264M | $10.3M | +4% |
Questions
How much did Celestica's revenue grow quarter over quarter in Q3 2026?
Celestica's revenue rose $1.1B (+24%) from $4.7B in Q2 2026 to $5.8B in Q3 2026.
What drove Celestica's revenue change in Q3 2026?
CCS +$1.1B (+28%); ATS +$69.1M (+8%).